Ponce School of Medicine Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2002
NCT00137696
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

t-den- f19 (1 trial)

tdenv-f17 (1 trial)

Drugs in Other Trials (1)

poliovirus vaccine inactivated (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dengue (Phase 2)

Fever (Phase 2)

Hemorrhagic Fevers, Viral (Phase 2)

Severe Dengue (Phase 2)

Shock (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3